BSX - Boston Scientific Corporation

NYSE - NYSE Delayed Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income1,671,000104,000347,000-239,000
Operating Activities, Cash Flows Provided By or Used In
Depreciation894,000844,000815,000766,000
Adjustments To Net Income-95,000412,000-186,000-162,000
Changes In Accounts Receivables-110,000-30,000-216,000-17,000
Changes In Liabilities-631,000195,000553,000-20,000
Changes In Inventories-83,000-107,00040,0003,000
Changes In Other Operating Activities-1,336,0008,000-171,000360,000
Total Cash Flow From Operating Activities310,0001,426,0001,182,000691,000
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-316,000-319,000-376,000-247,000
Investments-82,000-131,000-132,000-266,000
Other Cash flows from Investing Activities1,0001,0001,00061,000
Total Cash Flows From Investing Activities-1,921,000-1,010,000-887,000-2,186,000
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings1,405,000123,000-190,0001,385,000
Other Cash Flows from Financing Activities-74,000-98,000-127,000-223,000
Total Cash Flows From Financing Activities1,432,000110,000-206,0001,276,000
Effect Of Exchange Rate Changes-8,0004,000-2,000-4,000
Change In Cash and Cash Equivalents-188,000530,00087,000-223,000